poisar

Stocks · News reference

Elanco Animal Health Reports Third Quarter 2026 Financial Results

Elanco Animal Health Incorporated reported its third quarter 2026 financial results, featuring $1.265 billion in revenue and an adjusted EPS of $0.27, while updating its full-year 2026 guidance.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ELAN
Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Researchandmarkets.Com

    Mexico Animal Healthcare Market Size and Share Analysis - Industry Trends and Growth Forecasts (2026-2031) | Diagnostics and Pet Care Fuel Growth to USD 3.34 Billion

    Mexico's animal healthcare market is projected to grow from USD 2.13 billion in 2025 to USD 3.34 billion by 2031, with a CAGR of 7.84%. Growth is driven by rising companion animal spending, expanding livestock production, stronger biosecurity requirements, and innovation in veterinary diagnostics. Key challenges include high costs, limited rural infrastructure, and counterfeit medicines.

    ZTSMRKELANIDXXVBACY
  2. Earnings Transcripts

    Elanco Animal Health Q3 2026 Earnings Call Transcript

    Elanco Animal Health (NYSE:ELAN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga

    ELAN
  3. SEC EDGAR

    8-K filing — Elanco Animal Health Inc (ELAN)

    Filed: 2026-11-06 AccNo: 0001739104-26-000054 Size: 503 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

    ELAN